Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Banking.
Press releases published on April 8, 2025

AGF Management Limited Reports First Quarter 2025 Financial Results
TORONTO, April 08, 2025 (GLOBE NEWSWIRE) -- Reported quarterly adjusted diluted earnings per share of $0.48 Total assets under management and fee-earning assets of $53.8 billion Increased quarterly dividend per share to 12.5 cents AGF Management Limited ( …

La Société de Gestion AGF Limitée annonce ses résultats financiers pour le premier trimestre de l’exercice 2025
TORONTO, 08 avr. 2025 (GLOBE NEWSWIRE) -- Résultat dilué ajusté par action de 0,48 $ pour le trimestre Actif géré et actifs donnant droit à des commissions totalisant 53,8 milliards $ Augmentation du dividende trimestriel par action à 12,5 cents La Société …

EvolveImmune Therapeutics Announces Translational Research Collaboration to Evaluate Expression of Novel Tumor Target in Muscle-Invasive Bladder Cancer
BRANFORD, Conn. and NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- EvolveImmune Therapeutics, an immuno-oncology company developing next-generation T cell engager biotherapeutics to overcome cancer cell resistance to current immunotherapies, today announced …

Real World Assets (RWA Inc.) Appoints Stephen Schueler to Board of Directors
COPENHAGEN, Denmark, April 08, 2025 (GLOBE NEWSWIRE) -- Real World Assets (RWA Inc.), a leader in the tokenization of real-world assets, is excited to announce the appointment of Stephen Schueler to its Board of Directors, effective immediately. Schueler …

La Société de Gestion AGF Limitée déclare un dividende pour le premier trimestre de 2025
TORONTO, 08 avr. 2025 (GLOBE NEWSWIRE) -- Le 7 avril 2025, le conseil d’administration de La Société de Gestion AGF Limitée a déclaré un dividende de 12,5 cents par action pour les actions de catégorie B sans droit de vote et pour les actions ordinaires de …

ECARX Announces Upsizing and Extension of Share Repurchase Program
SHANGHAI, April 08, 2025 (GLOBE NEWSWIRE) -- ECARX Holdings, Inc. (Nasdaq: ECX) (“ECARX” or “the Company”), a global mobility tech provider, today announced that the Company’s board of directors has approved an additional US$20 million in share repurchase …

Questor Announces Award of $2.4MM Contract
CALGARY, Alberta, April 08, 2025 (GLOBE NEWSWIRE) -- Questor Technology Inc. (“Questor”, the “Company”), listed on the TSX Venture Exchange under the ticker QST, has secured a $2.4 million contract to supply clean combustion solutions in Iraq. This Middle …

OTC Markets Group Welcomes TDG Gold Corp. to OTCQX
NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced TDG Gold Corp. (TSXV: TDG; OTCQX: TDGGF), a major mineral tenure holder …

Microbix Provides Business Updates
MISSISSAUGA, Ontario, April 08, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF) (“Microbix®” or the Company”), a life sciences innovator, manufacturer, and exporter, provides an update on U.S. and reciprocal tariff outcomes as …

Tariffs Set to Drive Up Electronics Prices—New Survey Shows 53% of Shoppers Are Holding Out for Sales
BOSTON, April 08, 2025 (GLOBE NEWSWIRE) -- As new U.S. tariffs take effect, the cost of laptops, smartphones, and other electronics could increase by up to 11%, according to a Joint Economic Committee analysis. With prices climbing, consumers are adapting— …

BioStem Technologies to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on April 14, 2025
POMPANO BEACH, Fla., April 08, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, announces that …

Algernon Pharmaceuticals Receives Notice of Allowance from European Patent Office for Repirinast for Kidney Disease
VANCOUVER, British Columbia, April 08, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce …

Aya Gold & Silver Reports High-Grade Drill Results at Boumadine, Extends Tizi Zone to 2.2km and Identifies New Regional Targets
MONTREAL, April 08, 2025 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) is pleased to announce new high-grade drill exploration results from its 2024 - 2025 program at Boumadine in the Kingdom of Morocco. …

Theratechnologies Receives FDA Approval of Prior Approval Supplement (PAS) for EGRIFTA SV® sBLA
FDA action allows for unrestricted distribution of EGRIFTA SV®, removing uncertainty with respect to all manufactured batches PAS approval follows recent FDA approval of new formulation, EGRIFTA WR™ MONTREAL, April 08, 2025 (GLOBE NEWSWIRE) -- …

Forsys Reports Positive Ore Sorting Testwork at Norasa
TORONTO, April 08, 2025 (GLOBE NEWSWIRE) -- Forsys Metals Corp. (TSX: FSY) (FSE: F2T) (NSX: FSY) (“Forsys” or the “Company”) Forsys is pleased to report on ore-sorting testwork at its Norasa Uranium project (“Norasa”1). Highlights Exploratory ore sorting …

Routine medical appointments and cancer screenings head in the wrong direction
ALEXANDRIA, Va., April 08, 2025 (GLOBE NEWSWIRE) -- When was the last time you saw your doctor? There’s been a change in how often U.S. adults are going to routine medical appointments and cancer screenings, and according to the Prevent Cancer Foundation’s …

Aya Or & Argent publie des résultats de forage à haute teneur à Boumadine, augmente l’étendue de la zone Tizi à 2,2 km et identifie de nouvelles cibles régionales
MONTRÉAL, 08 avr. 2025 (GLOBE NEWSWIRE) -- Aya Or & Argent Inc. (TSX : AYA; OTCQX : AYASF) (« Aya » ou la « Société ») a le plaisir d’annoncer de nouveaux résultats de forage d’exploration à haute teneur issus de son programme 2024-2025 à Boumadine dans le …

Tilray Brands Reports Q3 Fiscal 2025 Financial Results
Tilray Confirms No Current Impact of Tariffs Generated Net Revenue of $186 Million in the Third Quarter, $193 Million in Constant Currency; Strategic Initiatives and SKU Rationalization Impacted Revenue by $13 Million Tilray Beverage Expands U.S. …

EnviroGold Global Showcases Resilience to U.S. Tariffs and Leverages Stronger U.S. Dollar to Boost Growth
TORONTO, April 08, 2025 (GLOBE NEWSWIRE) -- EnviroGold Global Limited (CSE: NVRO | OTCQB: ESGLF | FSE: YGK) (“EnviroGold” or the “Company”), a clean technology company that recovers valuable resources from mine waste while reducing environmental impact, …
![Theratechnologies reçoit l’approbation de la FDA pour le supplément d’approbation préalable [PAS] relatif à sa demande d’un supplément à la licence de produit biologique (sBLA) pour EGRIFTA SV(MD)](/images/pressrelease-small.png)
Theratechnologies reçoit l’approbation de la FDA pour le supplément d’approbation préalable [PAS] relatif à sa demande d’un supplément à la licence de produit biologique (sBLA) pour EGRIFTA SV(MD)
L’approbation de la FDA permet une distribution sans restriction d’EGRIFTA SVMD, levant ainsi l'incertitude concernant tous les lots fabriqués L’approbation du PAS fait suite à l’approbation récente de la nouvelle formulation, EGRIFTA WRMC MONTRÉAL, 08 avr …